Illinois House Resolution 158 calls for an investigation into the 340B Drug Pricing Program's use by Illinois hospitals.

Illinois House Resolution 158 directs the Auditor General to investigate the 340B Drug Pricing Program's use by Illinois hospitals. The resolution aims to assess the program's impact on state health programs, including Medicaid and the State Employees Group Insurance Program. It seeks to determine the program's effectiveness in serving vulnerable patients and the transparency of its practices. The investigation will examine the program's profit margins, the distribution of funds to pharmacy benefit managers and contract pharmacies, and the extent to which discounts are passed on to patients.

Illinois House Resolution 158 calls for an investigation into the 340B Drug Pricing Program's use by Illinois hospitals.

Illinois House Resolution 158 directs the Auditor General to investigate the 340B Drug Pricing Program's use by Illinois hospitals. The resolution aims to assess the program's impact on state health programs, including Medicaid and the State Employees Group Insurance Program. It seeks to determine the program's effectiveness in serving vulnerable patients and the transparency of its practices. The investigation will examine the program's profit margins, the distribution of funds to pharmacy benefit managers and contract pharmacies, and the extent to which discounts are passed on to patients.